Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M, Utsunomiya A, Koga S, Yamada Y, Kamihira S, Okayama A, Kikuchi H, Uozumi K, Yamaguchi K, Higashihara M, Umezawa K, Watanabe T, Horie R.
Watanabe M, et al. Among authors: watanabe t.
Blood. 2005 Oct 1;106(7):2462-71. doi: 10.1182/blood-2004-09-3646. Epub 2005 Jun 14.
Blood. 2005.
PMID: 15956280
Free article.